JD HEALTH (06618): Trustee purchased a total of 10.0534 million shares under the share award scheme
JD HEALTH (06618) announced that on November 18, 2026, the trustee purchased a total of 10.0534 million shares of the Company (the Shares) on the open market to satisfy the grant of awards under the post-IPO share award scheme (the Scheme).
JD HEALTH (06618) announced that on November 18, 2026, the trustee purchased a total of 10.0534 million shares of the Company (the Shares) on the open market to satisfy the grant of awards under the post-IPO share award scheme (the Scheme).
Related Articles

Breaking SpaceX's record! Anthropic (ANT.US) IPO raises $81.3 billion, priced above the guidance range, debuts on Nasdaq tonight

ABBISKO-B (02256) announced that its novel selective CDK4 inhibitor ABSK192 monotherapy and combination therapy preclinical research results were presented at the 2026 ENA Conference

HUTCHMED (00013): Announces Preclinical Data for HMPL-A830 at the 38th EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
Breaking SpaceX's record! Anthropic (ANT.US) IPO raises $81.3 billion, priced above the guidance range, debuts on Nasdaq tonight

ABBISKO-B (02256) announced that its novel selective CDK4 inhibitor ABSK192 monotherapy and combination therapy preclinical research results were presented at the 2026 ENA Conference

HUTCHMED (00013): Announces Preclinical Data for HMPL-A830 at the 38th EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics






